Aberrant splicing caused by a homozygous AK2 c.498 + 1G > A variant in a patient with reticular dysgenesis and concurrent B-cell acute lymphoblastic leukemia
Gene · 2027
DOI: 10.1016/j.gene.2026.150439 ↗Kurz gefasst
Fallbericht in der Zeitschrift Gene, 2027. Verfasst von Longkai He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology and Center for Newborn Care, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Severe Combined Immunodeficiency, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neutropenia. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangzhou Science and Technology Program Key Projects.
Abstract (Originalsprache)
Reticular dysgenesis (RD) is a rare autosomal recessive severe combined immunodeficiency characterized by profound neutropenia, T-cell lymphopenia and sensorineural hearing loss, and is caused by biallelic loss-of-function variants in AK2. We identified a homozygous AK2 splice-site variant (c.498 + 1G > A) in a boy with RD and concurrent B-cell acute lymphoblastic leukemia (B-ALL), a clinical combination not previously reported in association with an AK2 variant. An in vitro minigene assay showed that c.498 + 1G > A disrupts the canonical 5' splice donor site and generates an aberrant transcript carrying a 4-bp intronic insertion after exon 5, which causes a frameshift and introduces a premature termination codon; the transcript is predicted to be degraded by nonsense-mediated mRNA decay or, if translated, to yield a non-functional truncated protein, leading to loss of AK2 function. The variant was classified as pathogenic according to the ACMG/AMP criteria. As patient-derived material was unavailable, we re-analyzed publicly available RNA-seq data from AK2-knockout human hematopoietic stem and progenitor cells (GSE179320) and identified six hub genes (APOE, TREM2, CD68, CD36, IRF8 and CD163), which we further validated at the mRNA level in AK2-knockdown HL-60 cells, with IRF8 showing the most pronounced upregulation. This study characterizes the splicing defect caused by this variant and identifies candidate AK2-associated genes; the coexistence of RD and B-ALL is reported as a clinical observation requiring further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neonatology and Center for Newborn Care, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
- The Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
- Division of Neonatology and Center for Newborn Care, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. Electronic address: xpzhao717@126.com.
Förderung
- National Natural Science Foundation of China
- Guangzhou Science and Technology Program Key Projects
Zitieren
APA
He, L., Zhao, C., Lu, P., & Zhao, X. (2027). Aberrant splicing caused by a homozygous AK2 c.498 + 1G > A variant in a patient with reticular dysgenesis and concurrent B-cell acute lymphoblastic leukemia. Gene. https://doi.org/10.1016/j.gene.2026.150439
Vancouver
He L, Zhao C, Lu P, Zhao X. Aberrant splicing caused by a homozygous AK2 c.498 + 1G > A variant in a patient with reticular dysgenesis and concurrent B-cell acute lymphoblastic leukemia. Gene. 2027. doi:10.1016/j.gene.2026.150439
BibTeX
@article{He2027,
author = {He, Longkai and Zhao, Chunyan and Lu, Peng and Zhao, Xiaopeng},
title = {Aberrant splicing caused by a homozygous AK2 c.498 + 1G > A variant in a patient with reticular dysgenesis and concurrent B-cell acute lymphoblastic leukemia},
journal = {Gene},
year = {2027},
doi = {10.1016/j.gene.2026.150439}
}
EUVIMED